Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/2006
08/03/2006WO2005092062A3 Compounds for neurodegenerative disorders
08/03/2006US20060173193 e.g. [2-(1-(Benzenesulfonyl)-1H-indol-3-yloxy)ethyl]dimethylamine; serotonin, melatonin receptor ligand; antidepressant, anxiolytic agent; cognition activator; psychosis, schizophrenia, migraine headache, drug addiction, convulsions, osteoporosis, ischemic stroke, Alzheimer's, Parkinson's diseases
08/03/2006US20060173064 (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
08/03/2006US20060173058 Kcnq channel modulating compounds and their pharmaceutical use
08/03/2006US20060173044 Substituted propargylamines
08/03/2006US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity
08/03/2006CA2595728A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists
08/03/2006CA2594721A1 Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)-2-phthalimidomethylcyclopropane
08/02/2006EP1686157A1 Nonsolvate-form crystal of polymethine compound and process for producing the same
08/02/2006EP1685104A1 Processes for the preparation of n-substituted phthalimides
08/02/2006EP1685098A1 Ortho-substituted pentafluoride sulfanyl-benzenes, method for the production thereof and the use thereof in the form of valuable synthesis intermediate stages
08/02/2006EP1685094A1 Acylurea connected and sulfonylurea connected hydroxamates
08/02/2006EP1685091A1 M-diaminobenzoles and the acidic adducts thereof and use thereof in colouring agents
08/02/2006EP1565473B1 N,n-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors
08/02/2006EP1395242B1 Liquid pharmaceutical composition
08/02/2006EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
08/02/2006EP0970935B1 Method of separating optical isomers
08/02/2006CN1812979A Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
08/02/2006CN1812978A Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
08/02/2006CN1812977A Substituted carboxylic acids
08/02/2006CN1812971A Novel crystalline forms of perindopril erbumine.
08/02/2006CN1812790A 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor
08/02/2006CN1810817A Iridium complex of beta-diketone ligand and its electroluminescent device
08/02/2006CN1810789A Prepn of-2-(N-carbazolyl)-ethoxy carbohydrazide
08/02/2006CN1267438C antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole
08/02/2006CN1267433C Method for concurrent extracting sugarcane fat and chlorophyll from dross in sugar-refiney by using solvent
08/02/2006CN1267427C Process for production of citalopram
08/01/2006US7084281 Synthesis of dihalohydrins and tri- and tetra-substituted olefins
08/01/2006US7084169 Aminoalkoxyindoles and methods of use
08/01/2006US7084168 Indoline derivatives
08/01/2006US7084167 A secondary aminemethyl-indole derivatives, for treating diseases or physiological disorders; calcimimetic activity
08/01/2006US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors
08/01/2006US7084158 Substituted propargylamines
08/01/2006US7084154 Reducing pain
08/01/2006US7084143 N-(indolecarbonyl) piperazine derivatives
08/01/2006US7084136 Drug composition antagonistic to both PGD2/TXA2 receptors
08/01/2006CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/2006
07/27/2006WO2006077367A1 Indoles useful in the treatment of inflamation
07/27/2006WO2006077366A1 Indoles useful in the treatment of inflammation
07/27/2006WO2006077365A1 Indoles useful in the treatment of inflammation
07/27/2006WO2006077364A1 Indoles useful in the treatment of inflammation
07/27/2006WO2006077024A2 5-aminoindole derivatives
07/27/2006WO2005117904A3 Phosphonate analogs of hiv integrase inhibitor compounds
07/27/2006WO2004033397A3 Activity-based probes, and methods of their preparation and use
07/27/2006US20060167274 Amorphous (sumatriptan) succinate
07/27/2006US20060167273 Novel method for synthesissing (2s,3as,7as)-perhydroindole-2-carboxylic acid and the esters thereof and the use thereof for perindopril synthesis
07/27/2006US20060167272 Intermediates for the production of polymethine compounds containing a desired counter ion with high purity and in high yields; improving the solubility in solvents, the compatibility with resins, the durability and the sensitivity to laser beams
07/27/2006US20060167271 Purified compounds that inhibit intracellular alphax4/paxillin binding
07/27/2006US20060167265 Process for making amlodipine, derivatives thereof, and precursors therefor
07/27/2006US20060167263 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease
07/27/2006US20060167244 Polymerisation inhibitor
07/27/2006US20060167077 Process for preparation of carvedilol
07/27/2006US20060167076 Acutumine and acutumine compounds synthesis and use
07/27/2006US20060167059 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
07/27/2006US20060167049 Terphenly derivatives, preparation thereof, compositions containing same
07/27/2006US20060167046 Histamine h3 receptor antagonists, preparation and therapeutic uses
07/27/2006US20060166999 Use of microsomal triglyceride transfer protein (MTP) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (PPTRL)
07/27/2006US20060166989 2-naphthamide derivatives
07/27/2006US20060166961 Cell adhesion inhibitors
07/27/2006US20060166894 Ace-inhibitors having antioxidant and no-donor activity
07/27/2006US20060166866 Cell adhesion inhibitors
07/27/2006US20060166859 Compounds and compositions for delivering active agents
07/27/2006US20060166034 Monoaminofluorene compound and organic light-emitting device using the same
07/27/2006US20060165649 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
07/27/2006US20060165599 Near infrared imaging agent
07/27/2006US20060165598 Using water soluble dyes; contrast media for fluorescence
07/27/2006DE102005003634A1 Triarylamin-Derivate II mit raumfüllenden Seitengruppen und Verwendung in elektrolumineszenten und elektrofotografischen Vorrichtung Triarylamine derivatives II with room-filling side groups and use in electroluminescent and electrophotographic apparatus
07/27/2006CA2594878A1 Indoles useful in the treatment of inflammation
07/27/2006CA2594777A1 Indoles useful in the treatment of inflamation
07/27/2006CA2594773A1 Indoles useful in the treatment of inflammation
07/27/2006CA2594487A1 5-aminoindole derivatives
07/27/2006CA2593155A1 Indoles useful in the treatment of inflammation
07/26/2006EP1682530A1 Substituted pyrrole-indoles as inhibitors of pai-1
07/26/2006EP1682502A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
07/26/2006EP1682498A1 Novel prostamides for the treatment of glaucoma and related diseases
07/26/2006EP1682145A1 1-alkylpiperazinyl-pyrrolidin-2,5-dione derivatives as adrenergic receptor antagonists
07/26/2006EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof
07/26/2006EP1682121A1 Use of crth2 antagonist compounds in therapy
07/26/2006EP1140827B1 Synthesis of phenolic monomers containing imide or diimide moieties and high heat carbonate polymers prepared therefrom
07/26/2006CN1809535A Method of separating optically active dihydroxy-heptenoic acid esters
07/26/2006CN1807429A Use of fern in extracting harringtonine or homoharringtonine
07/26/2006CN1807413A Carbazole sulfonamide derivative and its preparation method
07/26/2006CN1807412A Indole-3-formic acid purification process
07/26/2006CN1266693C Optical recording material and optical disk using same
07/26/2006CN1266132C Amide derivative of indole, its preparation method and application
07/26/2006CN1266131C Process for the preparation of heterocgclic indene analogs
07/26/2006CN1266130C Ester derivative of indole, its preparation method and application
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2006US7081540 Pigment compositions and pigmented water-based coating materials
07/25/2006US7081473 Glucose dependent-insulinotropic polypeptide, or gastric inhibitory polypeptide (GIP) inhibitors; p-methylidene hydrizide phenols
07/25/2006US7081472 Reacting a substituted bis- indole compound with a chelating agent
07/25/2006US7081471 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
07/25/2006US7081470 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
07/25/2006US7081466 anticarcinogenic agents with improved efficacy against multidrug resistant tumors; improved oral bioavailability and side effect reduction
07/25/2006US7081464 enzyme inhibitors of tumor necrosis factor alpha and phosphodiesterase; anticachetic, antiasthmatic, antiinflammatory agents
07/25/2006US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone
07/25/2006CA2395869C 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
07/25/2006CA2259218C Tetrahydrobenzindole compound
07/20/2006WO2006076529A1 Indole derivatives for treating viral infections
07/20/2006WO2006075638A1 Novel heteroaryl derivative